Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Henry Khederian

Cassava Sciences (SAVA) Stock Is Surging Tuesday: What's Going On?

Gloves,,Test,And,Doctor,With,Medicine,,Syringe,Or,Preparing,Of

Cassava Sciences Inc (NASDAQ:SAVA) shares are trading higher Tuesday morning after a Form 4 filing disclosed that CEO Rick Barry acquired 237,941 shares at an average price of $2.25 each.

What To Know: Barry’s insider purchase injects a dose of confidence following the company’s decision earlier this year to discontinue the development of its Alzheimer’s drug, simufilam. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.